| Literature DB >> 31561430 |
Dumitru A Iacobas1,2, Sanda Iacobas3, Philip R Lee4, Jonathan E Cohen5, R Douglas Fields6.
Abstract
Transcriptional responses to the appropriate temporal pattern of action potential firing are essential for long-term adaption of neuronal properties to the functional activity of neural circuits and environmental experience. However, standard transcriptome analysis methods can be too limited in identifying critical aspects that coordinate temporal coding of action potential firing with transcriptome response. A Pearson correlation analysis was applied to determine how pairs of genes in the mouse dorsal root ganglion (DRG) neurons are coordinately expressed in response to stimulation producing the same number of action potentials by two different temporal patterns. Analysis of 4728 distinct gene-pairs related to calcium signaling, 435,711 pairs of transcription factors, 820 pairs of voltage-gated ion channels, and 86,862 pairs of calcium signaling genes with transcription factors indicated that genes become coordinately activated by distinct action potential firing patterns and this depends on the duration of stimulation. Moreover, a measure of expression variance revealed that the control of transcripts abundances is sensitive to the pattern of stimulation. Thus, action potentials impact intracellular signaling and the transcriptome in dynamic manner that not only alter gene expression levels significantly (as previously reported) but also affects the control of their expression fluctuations and profoundly remodel the transcriptional networks.Entities:
Keywords: DRG neurons; calcium signaling; calcium voltage-dependent channels; covariance analysis; gene expression variability; potassium voltage-gated channels; sodium voltage-gated channels; transcription factors
Mesh:
Substances:
Year: 2019 PMID: 31561430 PMCID: PMC6826514 DOI: 10.3390/genes10100754
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Figure 1Average relative expression variability (REV) (A) and normalized median expression (B) of all quantified (ALL, 13,974 distinct genes), calcium signaling related genes (CAS, 93 genes) and transcription factors (TRF, 934 genes) after electrical stimulation at two different patterns for 2 and 5 h. The means of the REV distributions in stimulated conditions were significantly different from the control (unstimulated) ones as measured by the p-values of the heteroscedastic (two-sample unequal variance) t-test of the two means equality: 18/1 2 h (ALL < 10 −308; CAS 6.28 × 10 −6; TRF 3.78 × 10 −51), 18/1 5 h (ALL 3.2 × 10 −216; CAS 2.76 × 10 −11; TRF 2.14 × 10 −132), 90/5 2 h (ALL <10 −308; CAS 3.59 × 10 −9; TRF 2.557 × 10 −97), 90/5 5 h (ALL <10 −308; CAS 7.10 × 10 −6; TRF 1.52 × 10 −37).
Relative expression variability (REV) scores and average expression levels for the most stably (low REV, blue background) and unstably (high REV, purple background) expressed calcium signaling genes and transcription factors in each stimulation paradigm.
| Gene | Description | Rev | Average Expression Level | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UNST | 18/1 2 h | 18/1 5 h | 90/5 2 h | 90/5 5 h | UNST | 18/1 2 h | 18/1 5 h | 90/5 2 h | 90/5 5 h | ||
| Itpkc | Inositol 1,4,5-trisphosphate 3-kinase C | 4.08 | 69.86 | 23.45 | 46.48 | 21.24 | 0.85 | 0.78 | 0.60 | 0.78 | 0.88 |
| Phka1 | Phosphorylase kinase alpha 1 | 5.09 | 28.95 | 74.08 | 58.14 | 37.93 | 1.63 | 1.47 | 3.55 | 1.97 | 2.01 |
| P2rx4 | Purinergic receptor P2X, ligand-gated ion channel 4 | 16.37 | 3.95 | 112.25 | 117.08 | 19.17 | 9.29 | 10.71 | 26.82 | 25.88 | 12.50 |
| Camk2g | Calcium/calmodulin-dependent protein kinase II gamma | 34.96 | 9.81 | 22.38 | 15.84 | 45.57 | 10.06 | 7.05 | 8.58 | 8.90 | 8.11 |
| Itpr1 | Inositol 1,4,5-trisphosphate receptor 1 | 40.17 | 55.94 | 10.70 | 77.73 | 71.53 | 0.42 | 0.41 | 1.31 | 0.54 | 0.46 |
| Nos3 | Nitric oxide synthase 3, endothelial cell | 16.83 | 43.24 | 15.12 | 112.12 | 51.14 | 0.44 | 0.46 | 0.39 | 0.38 | 0.43 |
| Ptger1 | Prostaglandin E receptor 1 (subtype EP1) | 43.58 | 36.53 | 49.36 | 13.32 | 30.79 | 0.50 | 0.35 | 0.60 | 0.42 | 0.47 |
| P2rx3 | Purinergic receptor P2X, ligand-gated ion channel, 3 | 35.66 | 32.39 | 37.78 | 14.48 | 44.31 | 3.43 | 3.04 | 2.77 | 4.01 | 3.69 |
| Prkacb | Protein kinase, cAMP dependent, catalytic, beta | 18.42 | 65.01 | 79.03 | 32.26 | 14.03 | 2.90 | 2.37 | 4.47 | 2.69 | 2.66 |
| Tnnc2 | Troponin C2, fast | 38.88 | 16.41 | 104.57 | 65.73 | 14.63 | 0.15 | 0.18 | 0.38 | 0.16 | 0.18 |
| Gna14 | Guanine nucleotide binding protein, alpha 14 | 111.31 | 108.18 | 65.77 | 91.80 | 135.19 | 2.38 | 2.89 | 4.46 | 2.43 | 2.29 |
| Itpka | Inositol 1,4,5-trisphosphate 3-kinase A | 135.85 | 70.23 | 43.64 | 52.15 | 50.27 | 0.31 | 0.27 | 0.31 | 0.36 | 0.48 |
| Adcy8 | Adenylate cyclase 8 | 53.29 | 140.51 | 129.81 | 161.86 | 49.72 | 0.31 | 0.28 | 0.19 | 0.33 | 0.30 |
| Adcy1 | Adenylate cyclase 1 | 72.76 | 187.74 | 83.73 | 96.58 | 49.77 | 1.18 | 0.93 | 2.03 | 1.66 | 1.20 |
| Cacna1i | Calcium channel, voltage-dependent, alpha 1I subunit | 15.41 | 13.73 | 241.17 | 111.72 | 41.66 | 0.17 | 0.15 | 2.12 | 0.14 | 0.28 |
| P2rx6 | Purinergic receptor P2X, ligand-gated ion channel, 6 | 43.00 | 81.81 | 247.15 | 69.38 | 78.50 | 0.18 | 0.19 | 4.19 | 0.21 | 0.22 |
| Atp2b4 | ATPase, Ca++ transporting, plasma membrane 4 | 32.40 | 27.58 | 64.75 | 185.86 | 19.62 | 0.22 | 0.20 | 0.19 | 0.38 | 0.27 |
| Pdgfrb | Platelet derived growth factor receptor, beta polypeptide | 89.66 | 59.63 | 71.95 | 189.03 | 53.23 | 1.11 | 1.09 | 3.97 | 4.29 | 1.19 |
| Phkb | Phosphorylase kinase beta | 18.64 | 59.47 | 91.03 | 46.67 | 114.62 | 0.53 | 0.46 | 1.01 | 0.70 | 0.64 |
| Gna14 | Guanine nucleotide binding protein, alpha 14 | 111.31 | 108.18 | 65.77 | 91.80 | 135.19 | 2.38 | 2.89 | 4.46 | 2.43 | 2.29 |
| Psmd4 | Proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 | 3.58 | 41.88 | 22.38 | 27.56 | 19.04 | 7.99 | 8.28 | 8.58 | 9.88 | 8.81 |
| Meis3 | Meis homeobox 3 | 4.79 | 44.56 | 105.78 | 82.12 | 42.64 | 4.43 | 4.09 | 9.58 | 8.58 | 5.77 |
| Hes2 | Hairy and enhancer of split 2 (Drosophila) | 60.24 | 3.20 | 118.34 | 92.56 | 22.53 | 0.14 | 0.13 | 0.95 | 0.45 | 0.15 |
| Dmap1 | DNA methyltransferase 1-associated protein 1 | 8.75 | 3.36 | 112.71 | 56.49 | 32.57 | 7.51 | 7.67 | 5.26 | 7.70 | 9.23 |
| Zscan26 | Zinc finger and SCAN domain containing 26 | 37.80 | 59.71 | 4.11 | 57.66 | 71.56 | 2.73 | 2.57 | 5.16 | 2.36 | 2.18 |
| Zfp454 | Zinc finger protein 454 | 71.95 | 35.51 | 6.34 | 75.85 | 56.53 | 0.30 | 0.26 | 0.74 | 0.76 | 0.26 |
| Zfpm1 | Zinc finger protein, multitype 1 | 57.82 | 27.68 | 31.25 | 3.00 | 32.40 | 1.98 | 1.44 | 1.54 | 1.28 | 1.88 |
| Ebf1 | Early B cell factor 1 | 21.01 | 50.60 | 41.41 | 10.42 | 45.89 | 5.05 | 4.48 | 12.31 | 7.42 | 4.10 |
| Lmx1b | LIM homeobox transcription factor 1 beta | 44.43 | 29.51 | 130.55 | 137.91 | 1.37 | 0.23 | 0.22 | 0.92 | 0.44 | 0.33 |
| Irf3 | Interferon regulatory factor 3 | 13.04 | 21.88 | 55.66 | 47.89 | 4.79 | 5.91 | 6.49 | 6.11 | 6.77 | 7.51 |
| Fos | FBJ osteosarcoma oncogene | 234.09 | 37.80 | 36.62 | 42.38 | 41.18 | 0.98 | 2.70 | 5.22 | 4.63 | 6.20 |
| Hoxa11 | Homeobox A11 | 282.22 | 274.19 | 129.55 | 170.19 | 222.34 | 4.82 | 4.52 | 6.85 | 6.61 | 5.55 |
| Kit | Kit oncogene | 139.43 | 197.96 | 177.49 | 152.75 | 48.95 | 0.29 | 0.33 | 1.02 | 0.38 | 0.25 |
| Hoxa11 | Homeobox A11 | 282.22 | 274.19 | 129.55 | 170.19 | 222.34 | 4.82 | 4.52 | 6.85 | 6.61 | 5.55 |
| Esrrb | Estrogen related receptor, beta | 46.14 | 38.10 | 237.35 | 206.64 | 20.94 | 0.27 | 0.22 | 2.57 | 1.21 | 0.23 |
| Id3 | Inhibitor of DNA binding 3 | 90.45 | 77.58 | 244.49 | 144.85 | 85.30 | 1.05 | 1.23 | 2.20 | 2.13 | 1.06 |
| Sall4 | Sal-like 4 (Drosophila) | 30.32 | 16.78 | 72.94 | 186.67 | 18.01 | 1.12 | 1.15 | 73.32 | 36.72 | 1.14 |
| Esrrb | Estrogen related receptor, beta | 46.14 | 38.10 | 237.35 | 206.64 | 20.94 | 0.27 | 0.22 | 2.57 | 1.21 | 0.23 |
| Ski | Ski sarcoma viral oncogene homolog (avian) | 25.40 | 82.12 | 69.90 | 92.66 | 211.33 | 0.31 | 0.24 | 0.17 | 0.26 | 1.69 |
| Hoxa11 | Homeobox A11 | 282.22 | 274.19 | 129.55 | 170.19 | 222.34 | 4.82 | 4.52 | 6.85 | 6.61 | 5.55 |
Lower REV indicates stronger control of transcript abundance by the homeostatic mechanisms, while higher REV indicates relaxed control. As indicated in Methods, expression levels were normalized to the median expression of all quantified genes in that condition. Red/green background indicates significant up-/down-regulation with respect to unstimulated (UNST). Note that REV is not related to the average expression level although both gene expression characteristics change with stimulation paradigm.
Figure 2Pearson correlation of gene expressions. Percentage of (p < 0.05) significantly uncorrelated and positively or negatively correlated (A) calcium signaling (CAS–CAS) gene pairs, (B) transcription factor (TRF–TRF) gene pairs and (C) CAS–TRF gene pairs in all experimental conditions. Note that the percentage of positive coordination is substantially higher for the 18/1 stimulation pattern at 5 h and strong positive coordination of the calcium signaling genes with the transcription factors. The difference between 100% and sum of the represented percentages is composed by the gene-pairs whose coordination did not meet the statistical evidence to be categorized as significantly uncorrelated, or as significantly positively or negatively correlated.
Figure 3Expression regulation and coordination of some voltage-gated channels in stimulated DRG neurons. (A) unstimulated neurons. (B) neurons stimulated for 2 h with 18/1 pattern. (C) neurons stimulated for 5 h with 18/1 pattern. (D) neurons stimulated for 2 h with 90/5 pattern. (E) neurons stimulated for 5 h with 90/5 pattern. Red/green background of the gene symbol indicates significant up-/down-regulation of that gene in that stimulation condition with respect to unstimulated neurons. Yellow background indicates that the expression change was not statistically significant. Red/blue line indicates that the expressions of the linked genes are significantly positively/negatively correlated. Note the substantial differences among the stimulation paradigms. Missing lines indicate that the expression coordination between the corresponding genes were not statistically significant.
Figure 4Positive and negative expression coordination of the first 50 alphabetically ordered calcium signaling genes in each pattern of stimulation. (A) positive correlations in unstimulated neurons. (B) negative correlations in unstimulated neurons. (C) positive correlations in neurons stimulated for 2 h with 18/1 pattern. (D) negative correlations in neurons stimulated for 2 h with 18/1 pattern. (E) positive correlations in neurons stimulated for 5 h with 18/1 pattern. (F) negative correlations in neurons stimulated for 5 h with 18/1 pattern. (G) positive correlations in neurons stimulated for 2 h with 90/5 pattern. (H) negative correlations in neurons stimulated for 2 h with 90/5 pattern. (I) positive correlations in neurons stimulated for 5 h with 90/5 pattern. (J) negative correlations in neurons stimulated for 5 h with 90/5 pattern. A red/blue line indicates a statistically significant (p-value < 0.05) positive/negative coordination of the linked genes. Missing lines indicate that the expression coordination between the corresponding genes is not statistically significant.
Figure 5Positive and negative expression coordination of 50 alphabetically ordered, randomly selected transcription factor genes (TRF) in all experimental conditions. (A) positive correlations in unstimulated neurons. (B) negative correlations in unstimulated neurons. (C) positive correlations in neurons stimulated for 2 h with 18/1 pattern. (D) negative correlations in neurons stimulated for 2 h with 18/1 pattern. (E) positive correlations in neurons stimulated for 5 h with 18/1 pattern. (F) negative correlations in neurons stimulated for 5 h with 18/1 pattern. (G) positive correlations in neurons stimulated for 2 h with 90/5 pattern. (H) negative correlations in neurons stimulated for 2 h with 90/5 pattern. (I) positive correlations in neurons stimulated for 5 h with 90/5 pattern. (J) negative correlations in neurons stimulated for 5 h with 90/5 pattern. A red/blue line indicates a statistically significant (p-value < 0.05) positive/negative coordination of the linked genes. Missing lines indicate that the expression coordination is not statistically significant. As in the case of CAS genes, the TRF network responds to the action potential firing pattern.
Figure A1Comparison of the expression coordination of the 93 adequately quantified calcium signaling genes among stimulation paradigms. A red/blue/yellow square indicates a statistically significant (p value < 0.05) positive/negative/independent coordination while a blank square indicates lack of statistical significance to assess the type of coordination. Numbers indicate the percentages of gene pairs exhibiting statistically significant positive (S), negative (A) and independent (I) coordination in the respective pattern of stimulation.
Figure A2Part of the expression coordination of the all 93 quantified calcium signaling genes with 200 randomly selected (out of 934) transcription factors. A red/blue/ square indicates a statistically significant (p value < 0.05) positive/negative coordination, an yellow square indicates no correlation, while a blank square indicates lack of statistical significance to assess the type of correlation. Note the significantly higher degree of coordination between the transcription factors and the calcium signaling genes for the 5 h stimulation with the 18/1 pattern.
Gene expression coordination may be reversed by changing pattern or duration of the electrical stimulation.
| Calcium Signaling Genes | ||||
|---|---|---|---|---|
| Gene Pair | 90/5 2 h | Unstimulated | 18/1 2 h | 90/5 5 h |
| Adcy8-Calm2 | 0.93590 | −0.90817 | ||
| Adcy9-Calm1 | 0.95850 | −0.95630 | ||
| Adora2a-Cd38 | 0.93826 | −0.95238 | ||
| Adora2a-Oxtr | 0.93992 | −0.98837 | ||
| Adra1b-Camk2b | 0.93396 | −0.92631 | ||
| Agtr1b-Camk2b | 0.98624 | −0.90249 | ||
| Atp2b1-Camk4 | −0.90327 | 0.96986 | ||
| Atp2b3-Grm5 | −0.90199 | 0.99263 | ||
| Atp2b4-Calm2 | 0.91756 | −0.94692 | ||
| Atp2b4-Gna14 | 0.98172 | −0.94881 | −0.94881 | |
| Cacna1i-Gna14 | 0.95922 | −0.98677 | ||
| Cacna1i-Itpr1 | −0.94637 | 0.96679 | ||
| Calm2-Egfr | −0.90024 | 0.99080 | ||
| Camk2d-Egfr | −0.99649 | 0.92581 | ||
| Camk4-Itpkc | 0.92652 | −0.90723 | ||
| Egfr-Itpr1 | 0.90311 | −0.91124 | ||
| F2r-Grm5 | −0.90302 | 0.98162 | ||
| Transcription Factors | ||||
| Gene Pair | 18/1 2 h | UNSTIMULATED | 18/1 5 h | 90/5 2 h |
| Ahctf1-Grhl3 | 0.97253 | −0.90926 | ||
| Arid3a-Ctcf | 0.90668 | −0.95895 | ||
| Arid3a-Ctcf | 0.91114 | −0.94827 | ||
| Bhlha9-Gsk3b | 0.93771 | −0.98955 | ||
| Bnc2-Gsk3b | 0.96196 | −0.98325 | ||
| Camk1d-Cc2d1a | 0.92630 | −0.97453 | ||
| Camk1d-Hoxa7 | 0.94662 | −0.99943 | ||
| Camk1d-Hoxa9 | 0.97426 | −0.95027 | ||
| Camk1d-Hoxb3 | 0.97329 | −0.95391 | −0.99620 | |
| Cask-Hmgn3 | 0.93393 | −0.92576 | ||
| Ccnh-Gabpb1 | 0.97091 | −0.90340 | ||
| Cdk8-Hoxb2 | 0.98575 | −0.94405 | ||
| Cnot7-Hoxb3 | 0.98709 | −0.93779 | ||
| Ctcf-Hoxb3 | 0.99212 | −0.91724 | ||
| Dach2-Hoxb5 | −0.97088 | 0.96951 | ||
| Dpf1-Hmbox1 | 0.97469 | −0.90904 | ||
| Dpf1-Hoxb2 | 0.90242 | −0.92939 | ||
| Dpf2-Gsk3b | 0.95509 | −0.99496 | ||
| Ercc2-Hnrnpd | 0.99951 | −0.95748 | ||
| Ercc2-Hoxb3 | 0.91956 | −0.98387 | ||
| Fos-Gsk3b | 0.95949 | −0.91342 | ||
| Fos-Hoxb3 | 0.91623 | −0.93715 | ||
| Gsk3b-Hmgn3 | 0.91755 | −0.99482 | ||
| Hmbox1-Hoxb3 | 0.96990 | −0.94583 | ||
| Hoxa9-Hoxb4 | 0.94215 | −0.91487 | ||
Red/blue background indicates significant positive/negative Pearson correlation coefficient. CAS genes: Adcy8/9 (Adenylate cyclase 8/9), Adora2a (Adenosine A2a receptor), Adra1b (Adrenergic receptor, alpha 1b), Agtr1b (Angiotensin II receptor, type 1b), Atp2b1/3/4 (ATPase, Ca++ transporting, plasma membrane 1/3/4), Cacna1i (Calcium channel, voltage-dependent, P/Q type, alpha 1I subunit), Calm1/2 (Calmodulin 1/2), Camk2b/d, Camk4 (Calcium/calmodulin-dependent protein kinase II beta /delta, IV), Cd38 (CD38 antigen), Egfr (Epidermal growth factor receptor), F2r (Coagulation factor II (thrombin) receptor), Gna14 (Guanine nucleotide binding protein, alpha 14), Grm5 (Glutamate receptor, metabotropic 5), Itpkc (Inositol 1,4,5-trisphosphate 3-kinase C), Itpr1 (Inositol 1,4,5-trisphosphate receptor 1), Oxtr (Oxytocin receptor). TRFs: Ahctf1 (AT hook containing transcription factor 1), Arid3a (AT rich interactive domain 3A (BRIGHT-like)), Bhlha9 (Basic helix-loop-helix family, member a9), Bnc2 (Basonuclin 2), Camk1d (Calcium/calmodulin-dependent protein kinase ID), Cask (Calcium/calmodulin-dependent serine protein kinase (MAGUK family)), Cc2d1a (Coiled-coil and C2 domain containing 1A), Ccnh (Cyclin H), Cdk8 (Cyclin-dependent kinase 8), Cno7 (CCR4-NOT transcription complex, subunit 7), Ctcf (CCCTC-binding factor), Dpf1/2 (D4, zinc and double PHD fingers family 1/2), Ercc2 (Excision repair cross-complementing rodent repair deficiency, complementation group 2), Fos (FBJ osteosarcoma oncogene), Gabpb1 (GA repeat binding protein, beta 1), Grhl3 (Grainyhead-like 3), Gsk3b (Glycogen synthase kinase 3 beta), H2afy (H2A histone family, member Y), Hipk3 (Homeodomain interacting protein kinase 3), Hnrnpd (Heterogeneous nuclear ribonucleoprotein D), Hoxb3/4/5 (Homeobox B3/4/5).
Figure 6Pair-wise relevance (PWR) analysis of the interaction between 50 calcium signaling genes (CAS) and 50 transcription factors (TRF) in all patterns of stimulation. (A) unstimulated neurons. (B) neurons stimulated for 2 h with 18/1 pattern. (C) neurons stimulated for 5 h with 18/1 pattern. (D) neurons stimulated for 2 h with 90/5 pattern. (E) neurons stimulated for 5 h with 90/5 pattern. The medallions present the relevant TRF–CAS gene pairs (and their PWR scores) in each condition.